AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnof-M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Cenofi Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimnof-M1 Tablet PR

Diabex Duo tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels. Discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify its symptoms – sweating, dizziness, headache, trembling – and how to counter it with fast-acting glucose (e.g., sugary foods, fruit juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimnof-M1 Tablet PR

No text provided. Please provide the text you would like me to rephrase.

Uses of Glimnof-M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimnof-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidelines. Administer Glimnof-M1 Tablet PR with a meal.

Common Side effects of Glimnof-M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnof-M1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glimnof-M1 Tablet PR with a meal.

How Glimnof-M1 Tablet PR works:

Glimnof-M1 PR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnof-M1 Tablet PR with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimnof-M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation and Glimnof-M1 Tablet PR are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimnof-M1 Tablet PR, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimnof-M1 Tablet PR. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimnof-M1 Tablet PR to individuals with hepatic impairment. Dosage modifications for Glimnof-M1 Tablet PR may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, initiate Glimnof-M1 Tablet PR therapy at a reduced dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimnof-M1 Tablet PR :

Should you forget a Glimnof-M1 Tablet PR dose, take it immediately if you remember. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnof-M1 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimnof-M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimnof-M1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimnof-M1 Tablet PR and seek immediate medical attention.
Glimnof-M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glimnof-M1 is not suitable for treating type 1 DM.
Glimnof-M1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimnof-M1 Tablet PR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 at least annually is recommended by some researchers.
Glimnof-M1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimnof-M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Glimnof-M1 Tablet PR
40
MRP 49
18% off